<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Nantawat Siritanan และผู้แต่งคนอื่นๆ. (2019) Efficacy and safety of brand-to-generic Tamsulosin for treating lower urinary tract symptoms associated with benign prostatic hyperplasia,A randomized, non-inferiority study. &lt;i&gt;Vajira Medical Journal&lt;/i&gt;, &lt;i&gt;63&lt;/i&gt;(6), 401-412.</APA><Chicago>Nantawat Siritanan และผู้แต่งคนอื่นๆ. "Efficacy and safety of brand-to-generic Tamsulosin for treating lower urinary tract symptoms associated with benign prostatic hyperplasia,A randomized, non-inferiority study". Vajira Medical Journal  63 (2019):401-412.</Chicago><MLA>Nantawat Siritanan และผู้แต่งคนอื่นๆ. Efficacy and safety of brand-to-generic Tamsulosin for treating lower urinary tract symptoms associated with benign prostatic hyperplasia,A randomized, non-inferiority study. Text and Journal Publication:ม.ป.ท. 2019.</MLA></bibliography></xml>
